Retrospective analysis of COVID-19 infection in CLL patients
Lydia Scarfò, MD, Vita-Salute San Raffaele University & IRCCS San Raffaele Scientific Institute, Milan, Italy, discusses the risk of COVID-19…
Related Articles
How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemia
Using 4 illustrative cases, Treon and colleagues discuss their approach to therapy in patients with Waldenström macroglobulinemia (WM) based on genomic pro
Future perspectives of radiation therapy for Hodgkin Lymphoma: Risk‐adapted, response‐adapted, and safer than before
Classical Hodgkin lymphoma is a lymphoproliferative disease with a good prognosis mainly seen in young people. Nevertheless secondary malignancy, cardiac disease and infertility may affect…
The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy
Aging Cell is an open access geroscience journal addressing the biology of aging, from molecular mechanisms of aging to age-related disease.
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
Tisagenlecleucel responses in patients with r/r FL remain highly durable a year after primary analysis; no new safety signals were observed.Low levels of L
Espacio Europeo de Datos Sanitarios (EEDS)
El Espacio Europeo de Datos Sanitarios es un ecosistema específico para la salud formado por reglas, normas y prácticas comunes, infraestructuras y un marco de…
New therapies for relapsed or refractory aggressive B‐cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group
Click on the article title to read more.
Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study
In the single-arm, open-label, multicenter, phase 2 PILOT study, second-line treatment with the chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel (liso-cel) in patients with…
VIDEO: Impacto del estado funcional en el tratamiento hematológico del paciente mayor | ScienceLink
Escuchar en Spotify: https://open.spotify.com/episode/2UINaPIMC7eDu3396f2w0W El Dr. Raúl Córdoba, hematólogo, Jefe Asociado de Hematología y Coordinador de la Unidad de Linfomas en el Hospital Universitario Fundación…
Analysis of @DrRaulCordoba FOLLOWERS
Mis seguidores viven en España(45%),Estados Unidos(22%),UK.(6%) y más tweepsmap.com/!DrRaulCordoba
Frailty assessment in the care of older people with haematological malignancies
Frailty, defined as an age-related state of increased vulnerability to acute stressors, is a major challenge in the care of older people with haematological malignancies.…